Journal of Immunotherapy & Precision Oncology Issues Research Articles in May 2024 Edition
June 24, 2024
June 24, 2024
CINCINNATI, Ohio, June 24 -- Journal of Immunotherapy and Precision Oncology, a peer-reviewed journal, published research articles on the following topics in its May 2024 edition (Vol. 7, Issue 2):
RESEARCH ARTICLES:
* Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies
* Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR)
. . .
RESEARCH ARTICLES:
* Phase Ib/II Study of Lacnotuzumab in Combination with Spartalizumab in Patients with Advanced Malignancies
* Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR)
. . .